PRO/AH/EDR> COVID-19 update (135): post-acute sequelae, women's health, Japan, WHO, global

COVID-19 — Worldwide/Unknown
Thrombosis and thrombocytopenia have been reported after vaccination with the ChAdOx1 nCoV-19 vaccine (Oxford-AstraZeneca), a recombinant chimpanzee adenoviral vector encoding the spike glycoprotein of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) [1,2]. To date, such reactions have not been associated with other vaccines against coronavirus 2019 (COVID-19). We describe a case of extensive thrombosis associated with severe thrombocytopenia and disseminated intravascular